{"id":745,"date":"2021-07-08T00:00:00","date_gmt":"2021-07-08T05:00:00","guid":{"rendered":"http:\/\/local.mindbloom.com\/blog\/decriminalization-legalization-regulation-whats-the-difference"},"modified":"2021-07-08T00:00:00","modified_gmt":"2021-07-08T05:00:00","slug":"decriminalization-legalization-regulation-whats-the-difference","status":"publish","type":"post","link":"https:\/\/www.todormanoilov.com\/blog\/decriminalization-legalization-regulation-whats-the-difference","title":{"rendered":"Decriminalization vs. Legalization vs. Regulation: What&#8217;s the Difference?"},"content":{"rendered":"<p>One can be forgiven for struggling to keep up with the legal status of different drugs and medicinal compounds in the United States. Knowing what drugs fall under what classification these days, depending where you are in the country can be tricky to navigate.<\/p>\n<p>Cannabis, for example, has come a long way since it was subjected to the \u201cReefer Madness\u201d treatment of the 1930s. Once a vilified and criminalized substance, marijuana is now legal, either medically or recreationally, in a majority of states in the U.S. That monumental shift is currently underway for certain psychedelic drugs, like psilocybin (mushrooms) and MDMA, which are proving to have promising results when treating the effects of certain mental health conditions, along with already legal ketamine. <\/p>\n<p>Mark Haden is an adjunct professor at the University of British Columbia and Director of Clinical Health at Psydin, a psychedelics and clinical trials company. He spoke to Mindbloom about the differences between decriminalization, legalization and regulation when it comes to the statuses of psychedelic medicines across local, state, and federal jurisdictions in the U.S.<\/p>\n<h3>Decriminalization <\/h3>\n<p>When a substance is decriminalized, it means that the substance is not criminalized and there are no criminal penalties for drug law violations. But Haden explains that there\u2019s degrees of decriminalization, which could apply to the amount of possession before the law kicks in, as well as severity of punishment.<\/p>\n<p>\u201cWith decriminalization, there might not be a criminal penalty, but civic ones, like a fine, could still apply,\u201d he says. \u201cDecriminalization is a scale, really, of the amount of civil and legal sanctions that apply to possession or sale of a substance.\u201d<\/p>\n<p>In February, Oregon became the first U.S. state to decriminalize possession of small amounts of \u201chard\u201d drugs, a decision that was made by ballot measure. That means anyone in the state caught with small amounts of psilocybin, LSD, MDMA, heroin, methamphetamine or other drugs can no longer be arrested by police. They can, however, still face a civil citation, the equivalent to a traffic ticket.<\/p>\n<p>In 2019, Denver, Colorado, became the first city in the U.S. to decriminalize hallucinogenic mushrooms, in an effort to cut back on city spending. The purpose and intent of the <a href=\"https:\/\/static1.squarespace.com\/static\/5bb4f9c27046803ce123a760\/t\/5c6360158165f54e1f1b090a\/1550016533926\/DPMDI.pdf\" target=\"_blank\" rel=\"noopener\">Denver Psilocybin Mushroom Initiative<\/a> was to deprioritize \u201cspending resources on imposing criminal penalties\u201d for the personal use and personal possession of psilocybin mushrooms.<\/p>\n<h3>Legalization<\/h3>\n<p>Legalization sits within the context of federal or state regulatory structure. In contrast, within the decriminalization structure, access to the substance is generally through illegal markets. <\/p>\n<p>With legalization, the substance becomes a regulated legal product and access comes from legal markets. However, the way legalization works varies widely.<\/p>\n<p>Oregon is the only state where psilocybin mushrooms are both decriminalized and legal, the latter of which is only designated for use in controlled therapeutic settings.<\/p>\n<p>You won\u2019t be able to buy them in a corner store or grow them at home, since it\u2019s the legalization of a service, rather than the legalization of the product. The only legal means of accessing psilocybin mushrooms in the state of Oregon is through a licensed professional. It is currently in a <a href=\"https:\/\/www.kgw.com\/article\/news\/local\/magic-mushroom-therapy-to-start-soon-in-oregon\/283-1b47538e-1a9d-482c-ac8d-6f8fe03b7575\" target=\"_blank\" rel=\"noopener\">two-year development plan<\/a> to hammer out the rules and regulations for the first-ever psilocybin therapy program in the country.<\/p>\n<p>And while the legalization and decriminalization of psilocybin is recognized in the state of Oregon, federally, the substance is still considered a <a href=\"https:\/\/www.dea.gov\/drug-information\/drug-scheduling\" target=\"_blank\" rel=\"noopener\">Schedule I substance<\/a> under the Controlled Substances Act.<\/p>\n<p>\u201cThere&#8217;s a variety of legal portholes that are opened up through the process of legalization so it\u2019s brought within the context of government in terms of how it\u2019s accessed,\u201d explains Haden. \u201cWhich government arm makes it available varies based on country and state.\u201d<\/p>\n<h3>Regulation<br \/><\/h3>\n<p>When a drug is legalized, an important part of the process is determining how it will be regulated. Rules and directives are established largely by government agencies that outline how a substance will be legalized, distributed, and\/or administered. <\/p>\n<p>For example the U.S.\u2019 Food and Drug Administration (FDA) determines which substances are available for on-label medicinal use \u2014 the use it\u2019s specifically approved for. But Haden explains the word \u201cregulation\u201d is broader than that for institutions like Canada\u2019s College of Physicians and Surgeons, and the professions that make it available, such as licensed clinicians.<\/p>\n<p>\u201cIn the [Canadian] context of psychedelics, if there\u2019s a regulated body, discipline, or profession that makes these things available, the profession that makes them available, like the psychedelic supervisors, the psychedelic guides, and the psychedelic therapists report to their College for oversight and training, and that\u2019s also regulation,\u201d he says. <\/p>\n<p>Ketamine, for example, is a drug that is currently legal to be prescribed for multiple on and off-label uses. While its initial FDA-approved application being as an anesthetic, it\u2019s also used off-label for pain management and mental health treatment.<\/p>\n<p>Ketamine has been observed to be useful at a lower dosage for depression and other mental health conditions. Its use in those contexts, such as major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and suicidal ideation, has only gone through <a href=\"https:\/\/www.mindbloom.com\/psychedelic-medicine\/psychedelic-medicine-pipeline\" target=\"_blank\" rel=\"noopener\">Phase 1 and 2 clinical trials in the FDA approval process<\/a> to prove its effectiveness, so it\u2019s currently used off-label.<\/p>\n<p>Only esketamine, a low dose ketamine nasal spray that\u2019s sold under the brand name Spravato, is available in the US as an on-label prescription specifically for treatment resistant depression, as it has passed Phase 3 clinical trials and FDA approval. <\/p>\n<p>Eskatmine is the s-isomer of racemic ketamine. Racemic ketamine has both the r-isomer &amp; s-isomer. Isomers mean they have the same chemical compound and makeup but are arranged differently. While ketamine\u2019s use in all situations hasn\u2019t been approved by the FDA, it\u2019s still able to be used off-label given its legal status.<\/p>\n<p>Another compound that\u2019s currently in the midst of being regulated for legalization in the U.S. is MDMA \u2014also known as \u201cecstacy\u201d or \u201cmolly.\u201d The drug has been found to have a positive effect for those with PTSD, when used along with talk therapy. Phase 3 clinical trials are complete, with recently published data set to be reviewed by the Federal Drug Administration. Its <a href=\"https:\/\/www.nytimes.com\/2021\/05\/03\/health\/mdma-approval.html\" target=\"_blank\" rel=\"noopener\">approval for therapeutic<\/a> use could come as early as 2023.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Defining key legal and regulatory terms when discussing psychedelic medicine and therapy.<\/p>\n","protected":false},"author":18,"featured_media":8,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.todormanoilov.com\/blog\/wp-json\/wp\/v2\/posts\/745"}],"collection":[{"href":"https:\/\/www.todormanoilov.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.todormanoilov.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.todormanoilov.com\/blog\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/www.todormanoilov.com\/blog\/wp-json\/wp\/v2\/comments?post=745"}],"version-history":[{"count":0,"href":"https:\/\/www.todormanoilov.com\/blog\/wp-json\/wp\/v2\/posts\/745\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.todormanoilov.com\/blog\/wp-json\/wp\/v2\/media\/8"}],"wp:attachment":[{"href":"https:\/\/www.todormanoilov.com\/blog\/wp-json\/wp\/v2\/media?parent=745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.todormanoilov.com\/blog\/wp-json\/wp\/v2\/categories?post=745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.todormanoilov.com\/blog\/wp-json\/wp\/v2\/tags?post=745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}